School of Medicine
Showing 231-240 of 251 Results
-
Peter Rudd, MD
Professor of Medicine (General Internal Medicine) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsQuality improvement efforts seek to make medical care the best it can be rather than merely good enough to avoid censure. Focus on improving the average performance usually produces more net benefit than eliminating outliers, often by simplification, standardization, and specification. We have worked with electronic medication monitors, clinical databases, and computerized order entry systems for better clinical outcomes and trained clinicians for professionalism and accountability.
-
Tope Rude, MD
Clinical Assistant Professor, Urology
BioDr. Rude is a board-certified, fellowship-trained urologist and pelvic reconstructive surgeon with Stanford Health Care Pelvic Health Center and the Stanford Urology Clinic. She is also a clinical assistant professor in the Department of Urology at Stanford University School of Medicine.
Dr. Rude specializes in pelvic medicine and reconstructive surgery. She is skilled in male and female genitourinary (urinary tract and reproductive organ) reconstruction, complex voiding dysfunction (issues with urinating), and neurourology (bladder problems related to spinal injuries and neurological disorders). She offers the full spectrum of care for pelvic organ prolapse, customized for the individual patient, and including vaginal surgery, robot assisted surgery, mesh augmented repairs, hysterectomy and obliterative procedures. She also offers broad surgical options for urethral reconstruction, including novel minimally invasive techniques, open repair with graft augmentation, and robot assisted repairs. Robotic approaches to care for distal ureteral stricture disease, neurogenic bladder and urinary fistula allow her to provide excellent outcomes for patients.
Her research interests include improving patient-reported outcomes after pelvic organ prolapse surgery, as well as the medical and surgical management of neurogenic (nervous system based) bladder and complex voiding dysfunction. She has also studied the interaction between race and prostate cancer treatment among the veteran population. Her active research endeavors include clinical trial of a novel implanted peripheral neuromodulation device for urgency incontinence and multi-center studies of voiding dysfunction.
Dr. Rude has received numerous awards, including winning first place in the socioeconomic category of the American Urologic Association’s (AUA) New York Section Annual Valentine Essay Contest. She also won best presentation at AUA’s Veteran Affairs Forum. Dr. Rude received the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Chemodenervation Grant and the National Institutes of Health/National Medical Association Travel Award.
Dr. Rude has published in several peer-reviewed journals, including Cancer, The Journal of Urology, and Urology. She has delivered presentations at the annual meetings of AUA and SUFU. In addition, she has presented at the World Congress of Endourology and Uro-Technology.
Dr. Rude is a member of AUA and SUFU. She is awas an inaugural fellow of the Well Black Woman Institute, which is part of The Foundation for Black Women’s Wellness in Madison, Wisconsin. -
Brian Ruhle, MD, MS
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Brian Ruhle is a board-certified surgeon with dual-fellowship training in minimally invasive bariatric (weight loss) surgery and endocrine surgery. He is also a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Ruhle specializes in bariatric surgery, foregut (upper digestive tract) surgery, adrenal surgery, and abdominal wall reconstruction. He uses leading-edge laparoscopic and robotic surgical techniques to help patients achieve sustainable weight loss and improve obesity-related health conditions. His expertise in advanced minimally invasive procedures offers patients significant benefits, including faster recoveries, reduced pain, and shorter hospital stays.
Dr. Ruhle’s research interests span a wide range of topics in metabolic and bariatric surgery. His studies have explored combination therapies for managing obesity, improvements in screening and treating endocrine disorders, and optimizing outcomes in thyroid and parathyroid surgeries. He has published his findings in many peer-reviewed journals, including Surgery, Journal of Gastrointestinal Surgery, and Journal of the American College of Surgeons.
Dr. Ruhle has presented at prominent national conferences, including the annual meetings of the American Association of Endocrine Surgeons and the American College of Surgeons Clinical Congress. His presentations have discussed using GLP-1 receptor agonists (weight loss medications that help regulate blood sugar and reduce appetite) before and after bariatric surgery. He has also addressed improving screening protocols for hyperaldosteronism (high blood pressure caused by excess production of the hormone aldosterone by the adrenal gland).
Dr. Ruhle is a member of the American Association of Endocrine Surgeons, the American Society for Metabolic and Bariatric Surgery, and the Society of American Gastrointestinal and Endoscopic Surgeons. -
Jessica L. Ruiz
Instructor, Pediatrics - Endocrinology
BioDr. Jessica Ruiz is a pediatric endocrinologist and Instructor at Stanford University and the Lucile Packard Children’s Hospital.
As a pediatrician-scientist and bioengineer, Dr. Ruiz's scholarly interest is pediatric type 2 diabetes. Her passion is to better predict, prevent and treat type 2 diabetes through digital phenotyping. Dr. Ruiz's vision is to apply data science and machine learning approaches to continuous glucose monitoring (CGM) data. Her work seeks to parameterize glucose kinetics to ultimately build CGM-based type 2 diabetes risk profiles. She is also involved in multiple clinical studies using dynamic CGM metrics to inform clinical care for patients with diabetes - including staging of diabetes as it develops.
Clinically, Dr. Ruiz enjoys caring for all pediatric patients seeking general endocrinology and diabetes care.
A native Texan, Dr. Ruiz obtained a B.S. in Bioengineering from Rice University (Houston, TX). She completed her M.D. at Harvard Medical School in the Harvard-MIT Health Sciences and Technology (HST) program (Boston, MA). She remained at Harvard to complete her training in Pediatrics in the Boston Combined Residency Program (Boston Children's Hospital and Boston Medical Center), followed by her training in Pediatric Endocrinology at Boston Children's Hospital. She was on the faculty at Boston Children's Hospital/Harvard Medical School as an Instructor for 2 years prior to moving to Stanford.
Dr. Ruiz also enjoys mentoring trainees and was formerly a Harvard Medical School Faculty Advisor and Associate Program Director for the Boston Children's Pediatric Endocrinology Fellowship Program. -
Cristin Runfola
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Runfola's research focuses on the epidemiology of dysregulated eating and weight concerns in undeserved populations and her primary interest is in developing and testing the efficacy of clinical interventions designed to improve outcome for eating disorders.
With support from GFED, Dr. Runfola adapted the Uniting Couples in the treatment of Anorexia Nervosa (UCAN) therapy manual for couples in which one or both members have binge-eating disorder (UNITE) and recently completed pilot testing on this treatment. She is in the process of expanding this treatment for all couples affected by binge eating, and is submitting a grant to fund future work testing efficacy. -
Stephen Ruoss
Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsWe have an active collaborative project examining basic and clinical aspects of non-tuberculous mycobacterial lung infection in non-immune compromised adults. Studies have examined possible cellular immune mechanisms for increased susceptibility to these infections, and are also investigating aspects of optimal diagnosis and treatment. In addition, a clinical and translational research program is investigating the causes and genetic factors underlying the evolution of bronchiectasis.